Metabolic Syndrome and Insulin Resistance Significantly Correlate with Body Mass Index

Archives of Medical Research

Volumn 39, Issue 8, 2008, Pages 803-808

  Esteghamati, Alireza ^a   Khalilzadeh, Omid ^a   Anvari, Mehdi ^a   Ahadi, Maral Seyed ^a   Abbasi, Mehrshad ^a   Rashidi, Armin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Homeostasis model assessment; Insulin resistance; Metabolic syndrome; Morbid; Obesity

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; IRAN; MALE; METABOLIC SYNDROME X; MORBID OBESITY; OBESITY; PREVALENCE; RISK FACTOR;

ADULT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; STATISTICS AS TOPIC;

EID: 55249117106     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2008.08.004     Document Type: Article

References (36)

1. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Grundy S.M., Hansen B., Smith Jr. S.C., Cleeman J.I., and Kahn R.A. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109 (2004) 551-556
3. Ferrannini E., Haffner S.M., Mitchell B.D., and Stern M.P. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34 (1991) 416-422
4. Laakso M. How good a marker is insulin level for insulin resistance?. Am J Epidemiol 137 (1993) 959-965
5. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
6. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
7. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495
8. World Health Organization. Obesity: Preventing and Managing the Global Epidemic (World Health Organization, Geneva, 1998).
9. Kim S.H., Abbasi F., and Reaven G.M. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 27 (2004) 1998-2002
10. Dalton M., Cameron A.J., Zimmet P.Z., Shaw J.E., Jolley D., Dunstan D.W., et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 254 (2003) 555-563
11. Jonsson S., Hedblad B., Engstrom G., Nilsson P., Berglund G., and Janzon L. Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. Int J Obes Relat Metab Disord 26 (2002) 1046-1053
12. Hu D., Hannah J., Gray R.S., Jablonski K.A., Henderson J.A., Robbins D.C., et al. Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: The Strong Heart Study. Obes Res 8 (2000) 411-421
13. Must A., Spadano J., Coakley E.H., Field A.E., Colditz G., and Dietz W.H. The disease burden associated with overweight and obesity. JAMA 282 (1999) 1523-1529
14. Mikkola I., Keinanen-Kiukaanniemi S., Laakso M., Jokelainen J., Harkonen P., Meyer-Rochow V.B., et al. Metabolic syndrome in connection with BMI in young Finnish male adults. Diabetes Res Clin Pract 76 (2007) 404-409
15. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
16. Mokdad A.H., Serdula M.K., Dietz W.H., Bowman B.A., Marks J.S., and Koplan J.P. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 282 (1999) 1519-1522
17. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., and Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163 (2003) 427-436
18. Cercato C., Mancini M.C., Arguello A.M., Passos V.Q., Villares S.M., and Halpern A. Systemic hypertension, diabetes mellitus, and dyslipidemia in relation to body mass index: evaluation of a Brazilian population. Rev Hosp Clin Fac Med Sao Paulo 59 (2004) 113-118
19. Cook S., Weitzman M., Auinger P., Nguyen M., and Dietz W.H. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 157 (2003) 821-827
20. Lemieux I., Drapeau V., Richard D., Bergeron J., Marceau P., Biron S., et al. Waist girth does not predict metabolic complications in severely obese men. Diabetes Care 29 (2006) 1417-1419
21. Adami G.F., Ravera G., Marinari G.M., Camerini G., and Scopinaro N. Metabolic syndrome in severely obese patients. Obes Surg 11 (2001) 543-545
22. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [article online]. 2006. Available from http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf, Accessed February 1, 2008.
23. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
24. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
25. Bosy-Westphal A., Geisler C., Onur S., Korth O., Selberg O., Schrezenmeir J., et al. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes (Lond) 30 (2006) 475-483
26. Brown C.D., Higgins M., Donato K.A., Rohde F.C., Garrison R., Obarzanek E., et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 8 (2000) 605-619
27. Huang Z., Willett W.C., Manson J.E., Rosner B., Stampfer M.J., Speizer F.E., et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med 128 (1998) 81-88
28. Stamler R., Stamler J., Riedlinger W.F., Algera G., and Roberts R.H. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA 240 (1978) 1607-1610
29. Grundy S.M. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 81 (1998) 18B-25B
30. Despres J.P., Moorjani S., Lupien P.J., Tremblay A., Nadeau A., and Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10 (1990) 497-511
31. Despres J.P., Allard C., Tremblay A., Talbot J., and Bouchard C. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism 34 (1985) 967-973
32. 2. Int J Obes Relat Metab Disord 25 (2001) 793-797
33. Ghiringhello M.T., Vieira J.G., Tachibana T.T., Ferrer C., Maciel R.M., Amioka P.H., et al. Distribution of HOMA-IR in Brazilian subjects with different body mass indexes. Arq Bras Endocrinol Metabol 50 (2006) 573-574
34. Gallagher D., Visser M., Sepulveda D., Pierson R.N., Harris T., and Heymsfield S.B. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?. Am J Epidemiol 143 (1996) 228-239
35. Ito H., Ohshima A., Ohto N., Ogasawara M., Tsuzuki M., Takao K., et al. Relation between body composition and age in healthy Japanese subjects. Eur J Clin Nutr 55 (2001) 462-470
36. Esteghamati A, Ashraf H, Rashidi A, Meysamie A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract 2008 Aug 13. [Epub ahead of print].